The effectiveness of chronic pelvic pain treatment in patients with endometriosis depending on the estrogen metabolite levels

The effectiveness of chronic pelvic pain treatment in patients with endometriosis depending on the estrogen metabolite levels

This article presents the results of studies 58 patients, mean age 29±1,7 years with chronic pelvic pain and laparoscopically confirmed diagnosis of external genital endometriosis. Based on the research results of estrogen metabolites has been allocated two groups studied patients. Group I – 26 pati...

Full description

Bibliographic Details
Main Authors: I B Manukhin, M V Prohorova, M A Gevorkyan, E I Manukhina, S O Smirnova
Format: Article
Language:Russian
Published: IP Berlin A.V. 2013-08-01
Series:Гинекология
Subjects:
pelvic pain
endometriosis
laparoscopy
estrogen metabolites
suppressive therapy
dienogest
Online Access:https://gynecology.orscience.ru/2079-5831/article/view/28218
id doaj-67458780da1f4622b614c1bfd1f0227e
record_format Article
spelling doaj-67458780da1f4622b614c1bfd1f0227e2020-11-25T03:04:45ZrusIP Berlin A.V. Гинекология2079-56962079-58312013-08-01154161825348The effectiveness of chronic pelvic pain treatment in patients with endometriosis depending on the estrogen metabolite levelsI B ManukhinM V ProhorovaM A GevorkyanE I ManukhinaS O SmirnovaThis article presents the results of studies 58 patients, mean age 29±1,7 years with chronic pelvic pain and laparoscopically confirmed diagnosis of external genital endometriosis. Based on the research results of estrogen metabolites has been allocated two groups studied patients. Group I – 26 patients (44,8%) with a predominance of carcinogenic fractions of estrogen in the urine of 2-ONE1/16-ONE1 least 2 (average 0,8±0,2), II group – 54 patients (55,2%) with normal estrоgen metabolism (average 2,3±0,3). Against the background of suppressive therapy with dienogest 2 mg after surgery in 12 months was significant (phttps://gynecology.orscience.ru/2079-5831/article/view/28218pelvic painendometriosislaparoscopyestrogen metabolitessuppressive therapydienogest
collection DOAJ
language Russian
format Article
sources DOAJ
author I B Manukhin
M V Prohorova
M A Gevorkyan
E I Manukhina
S O Smirnova
spellingShingle I B Manukhin
M V Prohorova
M A Gevorkyan
E I Manukhina
S O Smirnova
The effectiveness of chronic pelvic pain treatment in patients with endometriosis depending on the estrogen metabolite levels
Гинекология
pelvic pain
endometriosis
laparoscopy
estrogen metabolites
suppressive therapy
dienogest
author_facet I B Manukhin
M V Prohorova
M A Gevorkyan
E I Manukhina
S O Smirnova
author_sort I B Manukhin
title The effectiveness of chronic pelvic pain treatment in patients with endometriosis depending on the estrogen metabolite levels
title_short The effectiveness of chronic pelvic pain treatment in patients with endometriosis depending on the estrogen metabolite levels
title_full The effectiveness of chronic pelvic pain treatment in patients with endometriosis depending on the estrogen metabolite levels
title_fullStr The effectiveness of chronic pelvic pain treatment in patients with endometriosis depending on the estrogen metabolite levels
title_full_unstemmed The effectiveness of chronic pelvic pain treatment in patients with endometriosis depending on the estrogen metabolite levels
title_sort effectiveness of chronic pelvic pain treatment in patients with endometriosis depending on the estrogen metabolite levels
publisher IP Berlin A.V.
series Гинекология
issn 2079-5696
2079-5831
publishDate 2013-08-01
description This article presents the results of studies 58 patients, mean age 29±1,7 years with chronic pelvic pain and laparoscopically confirmed diagnosis of external genital endometriosis. Based on the research results of estrogen metabolites has been allocated two groups studied patients. Group I – 26 patients (44,8%) with a predominance of carcinogenic fractions of estrogen in the urine of 2-ONE1/16-ONE1 least 2 (average 0,8±0,2), II group – 54 patients (55,2%) with normal estrоgen metabolism (average 2,3±0,3). Against the background of suppressive therapy with dienogest 2 mg after surgery in 12 months was significant (p
topic pelvic pain
endometriosis
laparoscopy
estrogen metabolites
suppressive therapy
dienogest
url https://gynecology.orscience.ru/2079-5831/article/view/28218
work_keys_str_mv AT ibmanukhin theeffectivenessofchronicpelvicpaintreatmentinpatientswithendometriosisdependingontheestrogenmetabolitelevels
AT mvprohorova theeffectivenessofchronicpelvicpaintreatmentinpatientswithendometriosisdependingontheestrogenmetabolitelevels
AT magevorkyan theeffectivenessofchronicpelvicpaintreatmentinpatientswithendometriosisdependingontheestrogenmetabolitelevels
AT eimanukhina theeffectivenessofchronicpelvicpaintreatmentinpatientswithendometriosisdependingontheestrogenmetabolitelevels
AT sosmirnova theeffectivenessofchronicpelvicpaintreatmentinpatientswithendometriosisdependingontheestrogenmetabolitelevels
AT ibmanukhin effectivenessofchronicpelvicpaintreatmentinpatientswithendometriosisdependingontheestrogenmetabolitelevels
AT mvprohorova effectivenessofchronicpelvicpaintreatmentinpatientswithendometriosisdependingontheestrogenmetabolitelevels
AT magevorkyan effectivenessofchronicpelvicpaintreatmentinpatientswithendometriosisdependingontheestrogenmetabolitelevels
AT eimanukhina effectivenessofchronicpelvicpaintreatmentinpatientswithendometriosisdependingontheestrogenmetabolitelevels
AT sosmirnova effectivenessofchronicpelvicpaintreatmentinpatientswithendometriosisdependingontheestrogenmetabolitelevels
_version_ 1724679931527430144

Similar Items